Literature DB >> 20385352

Investigation of an apparent outbreak of Rhodococcus equi bacteremia.

Adam J Langer1, Kristina Feja, Brent A Lasker, Hans P Hinrikson, Roger E Morey, Gerald J Pellegrini, Theresa L Smith, Corwin Robertson.   

Abstract

During January to April 2007, hospital staff reported 3 patients with Rhodococcus equi bloodstream infections. Isolates were analyzed at the Centers for Disease Control and Prevention, Atlanta, GA, to confirm identification and to assess strain relatedness; 2 were R. equi but genetically distinct, and 1 was identified as Gordonia polyisoprenivorans. Rapid reference laboratory support prevented an unnecessary outbreak investigation. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20385352     DOI: 10.1016/j.diagmicrobio.2010.01.006

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  4 in total

Review 1.  Gordonia bronchialis bacteremia and pleural infection: case report and review of the literature.

Authors:  Jennifer A Johnson; Andrew B Onderdonk; Lisa A Cosimi; Sigal Yawetz; Brent A Lasker; Shanna J Bolcen; June M Brown; Francisco M Marty
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

2.  Gordonia bacteremia.

Authors:  Poornima Ramanan; Paul J Deziel; Nancy L Wengenack
Journal:  J Clin Microbiol       Date:  2013-07-24       Impact factor: 5.948

3.  Rhodococcus bacteremia in cancer patients is mostly catheter related and associated with biofilm formation.

Authors:  Fadi Al Akhrass; Iba Al Wohoush; Anne-Marie Chaftari; Ruth Reitzel; Ying Jiang; Mahmoud Ghannoum; Jeffrey Tarrand; Ray Hachem; Issam Raad
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

Review 4.  Bacteremia due to Gordonia polyisoprenivorans: case report and review of literature.

Authors:  Xiurong Ding; Yanhua Yu; Ming Chen; Chen Wang; Yanfang Kang; Hongman Li; Jinli Lou
Journal:  BMC Infect Dis       Date:  2017-06-12       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.